Pharmacist burnout is a significant issue resulting from chronic stress in the profession, affecting over 51% of pharmacists. It starts with emotional exhaustion, leading to reduced self-esteem and physical symptoms like headaches. Cognitive functions may also...
Miranda Wilhelm, PharmD discusses the unequal impact of the COVID-19 pandemic on different community groups, particularly racial and ethnic minorities who faced barriers in accessing vaccines. Community pharmacies played a vital role in administering COVID-19...
The Inflation Reduction Act (IRA), signed into law by President Biden in August 2022, is a significant piece of legislation aimed at tackling inflation by reducing the federal budget deficit. It also addresses key issues such as climate change, healthcare costs,...
The FDA has given its approval and emergency use authorization for updated COVID-19 vaccines, specifically designed to target the current variants of the virus. These updated vaccines are based on mRNA technology and are produced by Moderna (Spikevax) and Pfizer...
Chichi Ilonzo Momah, PharmD, RPh, had a lifelong calling to pharmacy, nurtured by her experiences in a Nigerian American family where she helped her grandparents understand their medications. Witnessing their struggles within the healthcare system inspired her to...
Artificial intelligence (AI) is transforming pharmacy practice by enhancing medication management, workflow efficiency, and patient outcomes. AI aids pharmacists in making informed decisions and reducing medication errors. It also plays a pivotal role in drug...
The FDA has extended the deadline for drug and device manufacturers, distributors, and others to comply with enhanced drug distribution security requirements under the Drug Supply Chain Security Act (DSCSA). Originally set for November 27, 2023, the new enforcement...
The Centers for Medicare & Medicaid Services (CMS) have chosen the first 10 prescription drugs for price negotiations under the Inflation Reduction Act. These drugs include various medications like apixaban, empagliflozin, rivaroxaban, sitagliptin, dapagliflozin,...
The pharmaceutical industry is grappling with drug shortages, and it's crucial to address this issue through strategies, technologies, and regulations.
Manufacturers need to embrace cutting-edge technologies, such as digital twins for predictive maintenance, AI for...